IL82720A0 - Recombinant polypeptide containing the amino acid sequence of the protein of feline leukemia virus,expression vehicles,plasmids coding for said protein,method for production thereof and pharmaceutical compositions - Google Patents

Recombinant polypeptide containing the amino acid sequence of the protein of feline leukemia virus,expression vehicles,plasmids coding for said protein,method for production thereof and pharmaceutical compositions

Info

Publication number
IL82720A0
IL82720A0 IL82720A IL8272087A IL82720A0 IL 82720 A0 IL82720 A0 IL 82720A0 IL 82720 A IL82720 A IL 82720A IL 8272087 A IL8272087 A IL 8272087A IL 82720 A0 IL82720 A0 IL 82720A0
Authority
IL
Israel
Prior art keywords
protein
production
leukemia virus
feline leukemia
amino acid
Prior art date
Application number
IL82720A
Other languages
English (en)
Original Assignee
Cambridge Bioscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Bioscience Corp filed Critical Cambridge Bioscience Corp
Publication of IL82720A0 publication Critical patent/IL82720A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL82720A 1986-05-30 1987-05-29 Recombinant polypeptide containing the amino acid sequence of the protein of feline leukemia virus,expression vehicles,plasmids coding for said protein,method for production thereof and pharmaceutical compositions IL82720A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86858586A 1986-05-30 1986-05-30

Publications (1)

Publication Number Publication Date
IL82720A0 true IL82720A0 (en) 1987-11-30

Family

ID=25351957

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82720A IL82720A0 (en) 1986-05-30 1987-05-29 Recombinant polypeptide containing the amino acid sequence of the protein of feline leukemia virus,expression vehicles,plasmids coding for said protein,method for production thereof and pharmaceutical compositions

Country Status (12)

Country Link
EP (1) EP0247904B1 (fr)
JP (1) JP2656521B2 (fr)
AT (1) ATE93394T1 (fr)
AU (1) AU607427B2 (fr)
DE (1) DE3787121T2 (fr)
DK (1) DK46988A (fr)
ES (1) ES2058113T3 (fr)
IL (1) IL82720A0 (fr)
NZ (1) NZ220500A (fr)
PT (1) PT84976B (fr)
WO (1) WO1987007301A1 (fr)
ZA (1) ZA873922B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152982A (en) * 1984-03-26 1992-10-06 Chiron Corporation Compositions and methods for FeLV vaccination
ES2179854T3 (es) * 1988-12-13 2003-02-01 Harvard College Materiales aislados de felv prototipos para uso en modelos de enfermedades y vacunas.
AU672372B2 (en) * 1991-11-08 1996-10-03 Pharmacia & Upjohn Company Feline leukemia virus vaccines
GB9210337D0 (en) * 1992-05-14 1992-07-01 Univ Court Of The University O Feline leukaemia virus vaccine
US6013506A (en) * 1995-06-05 2000-01-11 Wardley; Richard C. Feline leukemia virus vaccines
US6248582B1 (en) * 1997-10-08 2001-06-19 Imran Khan Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV
EP1757304A1 (fr) * 2005-08-26 2007-02-28 Bundesrepublik Deutschland vertreten durch das Bundesminsterium für Gesundheit, dieses vertr. durch das Robert-Koch-Institut Composition pharmaceutique et son utilisation pour le traitement prophylactique et thérapeutique des maladies rétrovirales

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406885A (en) * 1978-12-28 1983-09-27 Research Corporation Preparation of native oncornavirus envelope subunits and vaccines therefrom
US4264587A (en) * 1979-08-01 1981-04-28 Pedersen Niels C Vaccine for preventing persistent feline leukemia viremia in cats
US4434158A (en) * 1981-02-11 1984-02-28 Cornell Research Foundation Cysteine delivery system
US4701416A (en) * 1983-12-09 1987-10-20 Cetus Corporation Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
EP0156299A3 (fr) * 1984-03-26 1987-04-01 Chiron Corporation Vaccins viraux à LTR modifié
EP0173997A1 (fr) * 1984-09-06 1986-03-12 Chiron Corporation Vaccins protéiniques de virus de leucémie du chat et leur préparation
EP0203177A4 (fr) * 1984-11-29 1987-04-28 Scripps Clinic Res Polypeptides et anticorps associes a des glucoproteines virales depourvues de glucose.
AU607399B2 (en) * 1985-09-09 1991-03-07 Cetus Corporation Infectious recombinant virus vaccine for feline leukemia

Also Published As

Publication number Publication date
JP2656521B2 (ja) 1997-09-24
EP0247904B1 (fr) 1993-08-25
PT84976A (pt) 1987-06-01
NZ220500A (en) 1991-05-28
AU7547987A (en) 1987-12-22
DE3787121D1 (de) 1993-09-30
WO1987007301A1 (fr) 1987-12-03
DE3787121T2 (de) 1994-04-07
PT84976B (pt) 1990-02-08
ES2058113T3 (es) 1994-11-01
JPH01503273A (ja) 1989-11-09
AU607427B2 (en) 1991-03-07
DK46988D0 (da) 1988-01-29
ZA873922B (en) 1988-02-24
ATE93394T1 (de) 1993-09-15
EP0247904A1 (fr) 1987-12-02
DK46988A (da) 1988-01-29

Similar Documents

Publication Publication Date Title
DE3588022D1 (de) Pre-S-Gen kodierte Hepatitis-B immunogene Peptide, Vakzine, Diagnostika und synthetische lipidische Bläschenträger.
FI102075B1 (fi) Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit
CA2290485A1 (fr) Procede de production de proteines non immunogenes
WO1995029193A3 (fr) Antigenes du melanome
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
PT84427A (de) Hybridinterferone deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
EP0243913A3 (fr) Immunogènes peptidiques de l'hépatite B codés par le gène pre-S, vaccins, produits de diagnostic et vésicules de transport lipidique synthétiques
IL82720A0 (en) Recombinant polypeptide containing the amino acid sequence of the protein of feline leukemia virus,expression vehicles,plasmids coding for said protein,method for production thereof and pharmaceutical compositions
NO902251D0 (no) Fremstilling av gonorrheiske p1-proteiner og vaksiner.
GR3007031T3 (fr)
ES2009588A6 (es) Un metodo para la preparacion de un polipeptido.
EP0193585A4 (fr) Epitopes protecteurs et a reaction croisee de proteines de circumsporozoite.
WO1993014206A3 (fr) Peptides synthetiques destines a un vaccin contre la rubeole
SE8601940D0 (sv) Preparation of fused proteins, antibodies and processes therefor
GR3015074T3 (en) Recombinant treponema hyodysenteriae antigen and uses therefor.
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
EP0433378A4 (en) Allelic variants of -i(plasmodium falciparum) merozoite surface antigen
GR1000021B (el) Αντιπροσωπευτικο προιον ανοσιογενους ανασυνδυαζομενης ζυμης & μεθοδος καθαρισμου της.